Characteristic  With CSP (Prevalence) Male (Prevalence) Female (Prevalence) Without CSP (%) Male (%) Female (%)
Sample (N=479, 310 males, 169 females) 110 (22.96) 75(24.19) 35 (20.71) 369 (77.04) 235 (75.81) 134 (79.39)
Large CSP (% out of total CSP) 58/110 (52.73) 41/75 (54.66) 17/35 (48.57) - - -
Age total 57.44 ± 15.37 54.13 ± 14.55 53.27 ±10.15 55.61 ± 9.14 59.67 ± 14.88 58.57 ± 8.56 61.26 ± 10.23
Large CSP            
Age 52.25 ± 13.24 51.04 ± 11.17 54.21 ± 12.22      
Asymptomatic (normal by standard) 16/60 (26.67) 10/42 (23.81) 6/18 (33.33) 337/369 (91.32) 211/235 (89.79) 126/134 (94.03)
Symptomatic cava ≥ 6.0 mm            
Schizophrenia* 18/44 (40.91) 14/32 (43.75) 4/12 (33.33) 5/32 (15.62) 4/24 (16.67) 1/8 (12.5)
Alcoholism** 16/44 (36.36) 11/32 (34.38) 5/12 (41.67) 12/32 (37.50) 9/24 (30.75) 3/8 (37.5)
Brains with past head trauma** 10/44 (22.73) 7/32 (21.87) 3/12 (25) 15/32 (46.88) 11/24 (45.83) 4/8 (50) 
Symptomatic cava 44/60 (73.33) 32/42 (76.19) 12/18  (66.67) 32/369 (8.67) 24/235 (10.21) 8/134 (5.97)
TOTAL 60/110 (54.54) 42/75 (56) 18/32 (51.43) 369 235 134
Relative risk=15.78, **RR=23.24, ***RR=9.39, OR 4.52-19.38.
Table 1: Demographic data for the autopsy sample obtained in the study.